Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial.

Ignazio Carreca, Gianluca D'Aiuto, Luciana De Luca

Research output: Contribution to conferenceOther

Original languageEnglish
Pages170-170
Publication statusPublished - 2007

Cite this